Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Buchholz

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
Frontiers in Cardiovascular Medicine|October 12, 2023
Endothelial SARS-CoV-2 infection is not the underlying cause of COVID-19-associated vascular pathology in miceSiqi Gao, Alan T Tang, Min Wang, et al.
Biorxiv : the Preprint Server for Biology|August 7, 2023
Endothelial SARS-CoV-2 infection is not the underlying cause of COVID19-associated vascular pathology in miceSiqi Gao, Alan T Tang, Min Wang, et al.
Journal of Virology|February 14, 2020
Modified Sialic Acids on Mucus and Erythrocytes Inhibit Influenza A Virus Hemagglutinin and Neuraminidase FunctionsKaren N Barnard, Brynn K Alford-Lawrence, David W Buchholz, et al.
Stroke|January 8, 1999
Elevated tissue plasminogen activator antigen and stroke risk: The Stroke Prevention In Young Women StudyR F Macko, S J Kittner, A Epstein, et al.
Annals of Epidemiology|September 8, 2000
Distribution and correlates of elevated total homocyst(e)ine: the Stroke Prevention in Young Women StudyW H Giles, S J Kittner, J B Croft, et al.
Science Advances|September 22, 2023
Age-dependent acquisition of pathogenicity by SARS-CoV-2 Omicron BA.5Brian Imbiakha, Shahrzad Ezzatpour, David W Buchholz, et al.
Stroke|October 5, 2002
Antiphospholipid antibodies and stroke in young womenRobin L Brey, Christian L Stallworth, David L McGlasson, et al.
Stroke|January 4, 2001
Alcohol intake, type of beverage, and the risk of cerebral infarction in young womenA M Malarcher, W H Giles, J B Croft, et al.
Atherosclerosis|June 17, 2000
Lipoprotein (a) and the risk of ischemic stroke in young womenR J Wityk, S J Kittner, J L Jenner, et al.
Biochemical and Biophysical Research Communications|February 19, 2025
Novel nanobody drug conjugate as a prophylactic or therapeutic against SARS-CoV-2 infection in miceBrian Imbiakha, Shahrzad Ezzatpour, David W Buchholz, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Frontiers in Cardiovascular Medicine|October 12, 2023
Endothelial SARS-CoV-2 infection is not the underlying cause of COVID-19-associated vascular pathology in miceSiqi Gao, Alan T Tang, Min Wang, et al.
Biorxiv : the Preprint Server for Biology|August 7, 2023
Endothelial SARS-CoV-2 infection is not the underlying cause of COVID19-associated vascular pathology in miceSiqi Gao, Alan T Tang, Min Wang, et al.
Journal of Virology|February 14, 2020
Modified Sialic Acids on Mucus and Erythrocytes Inhibit Influenza A Virus Hemagglutinin and Neuraminidase FunctionsKaren N Barnard, Brynn K Alford-Lawrence, David W Buchholz, et al.
Stroke|January 8, 1999
Elevated tissue plasminogen activator antigen and stroke risk: The Stroke Prevention In Young Women StudyR F Macko, S J Kittner, A Epstein, et al.
Annals of Epidemiology|September 8, 2000
Distribution and correlates of elevated total homocyst(e)ine: the Stroke Prevention in Young Women StudyW H Giles, S J Kittner, J B Croft, et al.
Science Advances|September 22, 2023
Age-dependent acquisition of pathogenicity by SARS-CoV-2 Omicron BA.5Brian Imbiakha, Shahrzad Ezzatpour, David W Buchholz, et al.
Stroke|October 5, 2002
Antiphospholipid antibodies and stroke in young womenRobin L Brey, Christian L Stallworth, David L McGlasson, et al.
Stroke|January 4, 2001
Alcohol intake, type of beverage, and the risk of cerebral infarction in young womenA M Malarcher, W H Giles, J B Croft, et al.
Atherosclerosis|June 17, 2000
Lipoprotein (a) and the risk of ischemic stroke in young womenR J Wityk, S J Kittner, J L Jenner, et al.
Biochemical and Biophysical Research Communications|February 19, 2025
Novel nanobody drug conjugate as a prophylactic or therapeutic against SARS-CoV-2 infection in miceBrian Imbiakha, Shahrzad Ezzatpour, David W Buchholz, et al.
Pageof 12